CGON
Price
$26.90
Change
+$0.22 (+0.82%)
Updated
Jul 3 closing price
Capitalization
2.05B
32 days until earnings call
EXEL
Price
$46.15
Change
+$1.85 (+4.18%)
Updated
Jul 3 closing price
Capitalization
12.59B
37 days until earnings call
Interact to see
Advertisement

CGON vs EXEL

Header iconCGON vs EXEL Comparison
Open Charts CGON vs EXELBanner chart's image
CG Oncology
Price$26.90
Change+$0.22 (+0.82%)
Volume$349.45K
Capitalization2.05B
Exelixis
Price$46.15
Change+$1.85 (+4.18%)
Volume$6.04M
Capitalization12.59B
CGON vs EXEL Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. EXEL commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and EXEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CGON: $26.90 vs. EXEL: $46.15)
Brand notoriety: CGON: Not notable vs. EXEL: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 31% vs. EXEL: 167%
Market capitalization -- CGON: $2.05B vs. EXEL: $12.59B
CGON [@Biotechnology] is valued at $2.05B. EXEL’s [@Biotechnology] market capitalization is $12.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileEXEL’s FA Score has 2 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • EXEL’s FA Score: 2 green, 3 red.
According to our system of comparison, EXEL is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while EXEL’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 3 bearish.
  • EXEL’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EXEL is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а +3.18% price change this week, while EXEL (@Biotechnology) price change was +7.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

EXEL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXEL($12.6B) has a higher market cap than CGON($2.05B). EXEL YTD gains are higher at: 38.589 vs. CGON (-6.206). EXEL has higher annual earnings (EBITDA): 844M vs. CGON (-134.35M). EXEL has more cash in the bank: 1.03B vs. CGON (688M). CGON has less debt than EXEL: CGON (1.04M) vs EXEL (187M). EXEL has higher revenues than CGON: EXEL (2.3B) vs CGON (662K).
CGONEXELCGON / EXEL
Capitalization2.05B12.6B16%
EBITDA-134.35M844M-16%
Gain YTD-6.20638.589-16%
P/E RatioN/A21.07-
Revenue662K2.3B0%
Total Cash688M1.03B67%
Total Debt1.04M187M1%
FUNDAMENTALS RATINGS
EXEL: Fundamental Ratings
EXEL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
32
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONEXEL
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
72%
Momentum
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
65%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 11 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
61%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EXEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCIX33.570.36
+1.08%
MFS Mid Cap Growth I
NWAUX14.590.11
+0.76%
Nationwide GQG US Quality Eq A
SLVRX35.500.23
+0.65%
Columbia Select Large Cap Value R
LZSIX12.300.04
+0.33%
Lazard International Equity Select Instl
ETHSX12.86-0.03
-0.23%
Eaton Vance Worldwide Health Sci A

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+0.82%
IDYA - CGON
60%
Loosely correlated
+0.82%
SYRE - CGON
57%
Loosely correlated
+1.68%
ACLX - CGON
57%
Loosely correlated
+1.24%
NUVL - CGON
56%
Loosely correlated
-0.02%
KYMR - CGON
54%
Loosely correlated
+0.58%
More

EXEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with JAZZ. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then JAZZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXEL
1D Price
Change %
EXEL100%
+4.18%
JAZZ - EXEL
35%
Loosely correlated
-0.43%
RIGL - EXEL
29%
Poorly correlated
+1.50%
RVMD - EXEL
28%
Poorly correlated
+1.83%
CGON - EXEL
28%
Poorly correlated
+0.82%
UTHR - EXEL
28%
Poorly correlated
-0.25%
More